CNBC   |  February 25, 2013

Amgen: Top Performing on the Nasdaq 100

CNBC's Seema Mody reports on big movers in Biotech after Affymax and Takeda recalled an anemia drug named Omontys.

Share This:

Sorry, we do not have a transcript available for this video at this time.